×
AI startup helps patients overturn insurance denials
Written by
Published on
Join our daily newsletter for breaking news, product launches and deals, research breakdowns, and other industry-leading AI coverage
Join Now

AI-powered startup aims to empower patients in insurance battles: Claimable, a new AI-driven platform, launches to help patients challenge insurance denials and streamline access to necessary treatments.

  • Claimable, founded by physician-executive Warris Bokhari, utilizes large language models like GPT-4 to generate compelling appeals letters for patients facing insurance denials.
  • The startup focuses initially on rheumatology clinics, addressing challenges faced by patients requiring expensive biologic drugs for conditions like arthritis.
  • Claimable’s AI system is fine-tuned with up-to-date clinical guidelines, FDA labels, and trial data to create accurate and persuasive appeals.

The technology behind Claimable: The platform leverages advanced AI capabilities to transform patient stories into compelling arguments for insurance companies.

  • GPT-4 is used to summarize patient information at various reading levels, making complex medical data more accessible.
  • The AI system is trained on the latest guidelines from the American College of Rheumatology and other relevant medical information.
  • Claimable generates appeal letters for a flat fee of $39.95, aiming to make the service affordable and accessible to patients.

Early results and future plans: Initial pilot testing shows promising outcomes for patients using Claimable’s services.

  • The fully-automated software pilot phase has generated around 50 appeal letters with an 80% denial overturn rate.
  • Most cases have been resolved in under 10 days, significantly reducing waiting times for patients.
  • Claimable plans to expand its services to cover more than a hundred conditions by 2025, including multiple sclerosis, cardiac diseases, diabetes, obesity, asthma, and certain cancers.

The broader context: Claimable’s launch comes at a time when the healthcare industry is grappling with the implications of AI in administrative processes.

  • Industry experts predict a potential “battle of the bots” between healthcare providers and insurers over care decisions.
  • Patients often find themselves caught in the middle of these disputes, facing delays in accessing necessary treatments.
  • Claimable aims to shift the balance by putting AI tools directly in the hands of patients, empowering them to advocate for their own care.

Personal motivation and industry insights: Founder Warris Bokhari’s background and experiences shape Claimable’s mission and approach.

  • Bokhari’s mother suffered from rheumatoid arthritis, providing personal insight into the challenges faced by patients with chronic conditions.
  • His experience growing up in England, where his family didn’t face financial ruin due to medical expenses, informs his perspective on healthcare access.
  • Through the development process, Bokhari discovered that many insurance denials stem from outdated disease guidelines, highlighting a systemic issue in the industry.

Funding and growth: Claimable secures initial funding to support its development and expansion plans.

  • The startup has raised a seed round led by Walkabout Ventures, though the exact amount remains undisclosed.
  • This funding will support Claimable’s ambitious plans to expand its services across a wide range of medical conditions in the coming years.

Potential impact on healthcare administration: Claimable’s approach could have far-reaching implications for how patients interact with the healthcare system.

  • By automating and streamlining the appeals process, Claimable may reduce administrative burdens on both patients and healthcare providers.
  • The platform’s success could prompt insurance companies to reassess their denial processes and update their guidelines more frequently.
  • As AI continues to play a larger role in healthcare administration, tools like Claimable may become increasingly important in ensuring patient advocacy and access to care.

Looking ahead: Challenges and opportunities: While Claimable shows promise, its growth and impact will depend on various factors.

  • The startup will need to navigate complex regulatory landscapes as it expands to cover more medical conditions and potentially enters new markets.
  • As AI technology evolves, Claimable may need to continuously update and refine its algorithms to maintain accuracy and effectiveness.
  • The success of Claimable could inspire similar AI-driven solutions in other areas of healthcare administration, potentially leading to broader systemic changes in how patients interact with insurers and healthcare providers.
InnovationRx: This AI Startup Helps Patients Fight Insurance Denials

Recent News

AMD is developing an open-source software platform for AI development

AMD's open-source AI initiative aims to help developers build applications that can run on any manufacturer's chips, breaking away from hardware-specific development tools.

Apple’s AI model will supercharge Siri but don’t expect it any time soon

Apple's forthcoming Siri overhaul will process AI tasks directly on devices rather than in the cloud, prioritizing user privacy at the potential cost of advanced features.

.COM vs .AI: Choosing the right domain name for your startup

The surging AI sector has sparked intense competition for domain names, forcing startups to weigh the authority of .com against the thematic appeal of .ai extensions.